Characteristics and features of clinical manifestations of primary hyperaldosteronism (literature review)
| Autor: | Olexandr V. Shidlovskyi, Yan V. Gyrla, Nina P. Tkachuk, Natalia A. Sheremet, First City Polyclinic, Chernivtsi, Ukraine, Viktor O. Shidlovskyi, Vitaliy Vasilyevich Maksymyuk, Oleksandr V. Bilookyi, Michael Ivanovich Sheremet, Volodimir V. Tarabanchuk |
|---|---|
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Romanian Journal of Medical Practice, Vol 14, Iss 4, Pp 371-377 (2019) |
| ISSN: | 2069-6108 1842-8258 |
| DOI: | 10.37897/rjmp.2019.4.4 |
| Popis: | Introduction. Primary hyperaldosteronism as a cause of secondary arterial hypertension ranges from 4.6 to 13.0%, and among patients with refractory hypertension to medication therapy is about 20%. Meanwhile, its detectability among patients with arterial hypertension in centers of primary health care is from 6 to 13%, and in secondary care centers – from 23 to 30%. The high frequency of life-threatening cardiovascular complications dictates the need for early and timely diagnosis of primary hyperaldosteronism in the stages of the primary and secondary units of medical care. In addition, studies conducted in German and Italian hospitals among general practitioners showed a low level of knowledge about primary hyperaldosteronism. Objective. To promote the knowledge of general practitioners about clinical symptoms and clinical features of primary hyperaldosteronism. Results. Therefore, the main task of the work is the systematization and dissemination of knowledge for general practitioners about the symptoms and peculiarities of the clinical course of primary hyperaldosteronism. Such signs as an inadequate response to hypotensive therapy of a combination of three drugs, a manifestation of arterial hypertension under the age of 30, a rapid increase in blood pressure even in the elderly and/or the loss of efficacy of antihypertensive therapy, apnea in dream are distinguished in its non-specific clinical picture, without indicating priority. In the literature, there are recommendations to separate classical and secondary clinical manifestations. Classical include arterial hypertension, hypokalemia, hypervolemia, metabolic alkalosis, and minor ones such as headache, retinopathy, neuromuscular symptoms (paresthesia’s, convulsions, general weakness), carbohydrate metabolism disorders, arrhythmias, early onset of hypertrophy and fibrosis of the heart muscle and smooth muscle vessels, hypokalemia and moderate hypernatremia. Conclusions. In the clinical course of the disease, the cardiovascular, neuromuscular, renal and metabolic syndromes are distinguished, or in combination of several of them, in each particular case, the primary hyperaldosteronism may appeared (or manifested). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|